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Forty-four patients with primary ventricular fibrillation
or recurrent ventricular tachycardia were stabilized on
an antiarrhythmic drug regimen before electrophysio-
Illgic study and 24 to 72 hours of ambulatory electro-
cardiographic monitoring were performed. The long-
term predictive value of these two tests was then com-
pared retrospectively for a 12 to 32 month (mean 18)
follow-up period, during which all patients continued
receiving the same antiarrhythmic drug regimen. Elec-
trophysiologic testing induced ventricular tachycardia
(:~ 3 beats) in 26 patients; 23 had a poor clinical outcome
l positive predictive value 88%), defined as sudden death
nr sustained ventricular tachycardia. In 18 patients with
a negative electrophysiologic test, only 1 had a poor
clinical outcome (negative predictive value 94%).
With the development and refinement of clinical electro-
physiologic techniques, especially programmed electrical
stimulation, over the past decade, a new dimension has been
added to the management of patients with malignant ven-
tricular tachyarrhythmias such as ventricular tachycardia and
ventncular fibrillation (1-5). Before the introduction of pro-
grammed electrical stimulation, however, the traditional ap-
proach to the management of such patients included the use
of ambulatory electrocardiographic (Holter) monitoring to
document the presence of ventricular arrhythmias, and at-
tempts to ablate any demonstrated arrhythmias with one or
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Ambulatory electrocardiographic monitoring accu-
rately predicted outcome in 7 of 10 patients with a pos-
itive recording (positive predictive value 70%), defined
as three or more consecutive ventricular extrasystoles,
and in 17 of 34 patients with negative ambulatory mono
itor recordings (negativepredictive value50%). The long-
term predictive accuracy of the electrophysiologic study
was significantly higher than that of the ambulatory
electrocardiographic monitor (p < 0.001). Electrophys-
iologicstudies offer advantages over ambulatory electro-
cardiographic monitoring in this high risk patient group,
providing a' high degree of accuracy in predicting the
long-term clinical response to antiarrhythmic drugs for
at least 18 months.
more antiarrhythmic drugs (6,7). In this fashion, the ablation
of any ventricular arrhythmia demonstrable on ambulatory
monitoring has been used as an end point indicating adequate
response to antiarrhythmic drug treatment. A recent report
by Herling et al. (8) suggested that Holter monitoring was
not predictive of antiarrhythmic drug efficacy in a group of
patients with recurrent ventricular tachycardia.
Although the use of programmed electrical stimulation
is becoming more widespread and has been studied in sev-
eral groups of patients resuscitated from cardiac arrest
(2,9,10), there remains no comparative study of the roles
of Holter monitoring and electrophysiologic testing in pa-
tients who are survivors of sudden cardiac death. In this
study, we retrospectively examined and compared the pre-
dictive values of these two techniques in the clinical man-
agement of patients with recurrent ventricular tachycardia
or ventricular fibrillation.
Methods
Selection of patients. The study group consisted of 44
patients referred to The Johns Hopkins Hospital over a 2
year period who fulfilled the following four selection cri-
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teria: 1) they were successfully resuscitated at least once
from ventricular fibrillation or at least twice from sustained
symptomatic ventricular tachycardia, defined as causing
syncope or presyncope and requiring cardioversion for ter-
mination; 2) acute myocardial infarction had not occurred
in association with the cardiac arrest or for the preceding 2
weeks; 3) ventricular fibrillation or ventricular tachycardia
was demonstrated during electrocardiographic monitoring
before electrophysiologic study; and 4) ambulatory electro-
cardiographic (Holter) monitoring and electrophysiologic
study were both carried out just before discharge from the
hospital, with the antiarrhythmic drug regimen remaining
unaltered thereafter.
Study protocol. On the basis of these four selection
criteria, patients were admitted to the hospital and under-
went serial drug trials with evaluation using ambulatory
Holter monitoring and electrophysiologic studies. Although
a patient may have undergone multiple electrocardiographic
recordings and electrophysiologic studies, only the final
electrophysiologic study and concurrent Holter monitoring
records obtained before discharge or transfer were analyzed
for the purposes of this study. During these final evaluation
procedures, the antiarrhythmic drug regimen was unaltered
and remained unaltered during the follow-up period.
The approach used in the management of these patients
was carried out according to the following protocol: treat-
ment with conventional agents was always attempted first,
using quinidine, then procainamide, then disopyramide and
lastly, propranolol. Even though the patient may have re-
ceived one or more conventional agents before referral,
these were reevaluated unless the following criteria were
met: I) an antiarrhythmic agent would not be retried if there
was documented clinical toxicity or allergic reactions as-
sociated with therapeutic doses of the drug; 2) recurrent
ventricular tachycardia documented electrocardiographi-
cally or recurrent syncope associated with therapeutic doses
or blood levels (or both) of the antiarrhythmic agent; 3) in
addition, exceptions to the use of disopyramide would be
made if there was a history of New York Heart Association
class III or IV congestive heart failure or of urinary retention
or if the patient was an elderly man; and 4) propranolol was
not used in patients with class III or IV congestive heart
failure, a history of bronchospasm or insulin-requiring di-
abetes mellitus.
After the patients had met the requirements for conven-
tional antiarrhythmic therapy and had provided informed
consent, investigational antiarrhythmic agents were utilized,
although no specific sequence was followed.
The clinical therapeutic goal was the elimination of all
ventricular tachycardia from ambulatory electrocardio-
graphic monitoring and suppression of ventricular tachy-
cardia induced during electrophysiologic study. If ventric-
ular tachycardia was evident on ambulatory monitoring in
the hospital, the antiarrhythmic drug regimen was changed.
However, if this goal could not be attained, the patient was
discharged on the regimen that resulted in the greatest re-
duction in ventricular tachycardia defined as a salvo of three
or more ventricular ectopic beats at a rate of greater than
100 beats/min on the ambulatory monitor. The latter was
accepted at times, despite the induction of ventricular tachy-
cardia during electrophysiologic study.
Electropbysiologic studies. These were carried out with
electrode catheters inserted percutaneously through femoral
or antecubital veins and positioned under fluoroscopic guid-
ance at multiple intracardiac sites. Cardiac stimulation was
performed with a constant current programmable impulse
generator (Bloom Associates) that delivered rectangularpulses
of 1 ms duration at twice the diastolic threshold « 4 rnA).
Three or more catheters were used: a right atrial catheter,
His electrogram recording catheter, right ventricular catheter
and, when needed, a left ventricular catheter.
Modes of programmed stimulation included the V 1V2
mode, in which a single ventricular extrastimulus is intro-
duced after a ventriculardrive of eight beats. and the VIV2V3
mode, in which two ventricular extrastimuli are introduced
after a ventricular drive of eight beats. Extrastimuli were
made progressively more premature until ventricular re-
fractoriness resulted. Finally, the Vburst mode was also uti-
lized, consisting of rapid ventricular pacing for IO beats at
progressively shorter cycle lengths until ventricular refrac-
toriness is attained. At least two right ventricular sites were
tested at paced cycle lengths of 500 and 600 ms. If ven-
tricular tachycardia was not induced, programmed stimu-
lation was carried out at two left ventricular sites.
A positive electrophysiologic test was defined as the re-
producible (that is, occurring on at least two of three at-
tempts at the same prematurity interval) induction of three
or more beats of ventricular origin occurring by intraven-
tricular reentry, whether or not the patient was receiving
drug therapy (11,12). The end point of study was the in-
duction of sustained ventricular tachycardia, requiring either
overdrive pacing or external cardioversion for termination.
If nonsustained ventricular tachycardia was induced, the
study was continued. For the purposes of this study, non-
sustained ventricular tachycardia was defined as ventricular
tachycardia of three or more beats' duration and terminating
spontaneously within 30 seconds. Sustained ventricular
tachycardia was defined as ventricular tachycardia persisting
for more than 30 seconds or requiring termination earlier
because of hemodynamic embarrassment.
Holter monitoring. Inpatient ambulatory electrocardio-
graphic (Holter) monitoring was carried out near the time
of electrophysiologic study. with the antiarrhythmic regimen
being the same as that during the electrophysiologic study.
Avionics model 445 two channel recorders were used with
modified VI and V5 leads. All recordings were scanned by
an experienced technician with an Avionics Trendsetter.
Permanent records were obtained for each abnormality and
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were checked by one of us. A positive Holter monitor re-
cording was defined as one showing a salvo of three or more
beats (If ventricular tachycardia at a rate greater than 100
beats/min.
Follow-up. After discharge, patients were followed up,
either In our outpatient arrhythmia clinic or by the referring
cardiologist, or both. Follow-up information was obtained
from the patient and the patient's physician. A good clinical
response was defined as the absence of recurrent sudden
cardiac death or symptomatic sustained ventricular tachy-
cardia. documented by surface electrocardiographic record-
ing. A poor clinical response was defined as the presence
of recurrent sudden cardiac death or symptomatic sustained
ventricular tachycardia during the follow-up period. Sudden
cardiac death was defined as unheralded death occurring
within 1 hour of the onset of symptoms, or if the patient
was found dead in bed, in the absence of any change in
clinical status before going to bed.
Statistical analysis. The chi-square test and Fisher's ex-
act test were used in determining statistical significance of
the calculated predictive values. Life tables analyses were
performed according to the method of Kaplan and Meier
(13). The Wilcoxon method of comparing two life tables
was used (14).
Results
Patient characteristics. The age range of the 37 men
and 7 women was 22 to 79 years (mean 54). Thirty patients
(68%) had coronary artery disease, 12 (27%) had myocardial
disease, 1 (2%) had mitral valve prolapse, and 1 (2%) had
no identifiable heart disease. Twenty-one patients (48%) had
a history of resuscitation from at least one episode of primary
ventricular fibrillation, 18 of whom had two or more epi-
sodes Twenty-three patients (52%) had recurrent sustained
ventricular tachycardia on two or more occasions, requiring
medical intervention for termination. Patients with ventric-
ular fibrillation had a history of 3.1 ± 1.7 (SO) separate
episodes of ventricular fibrillation. Patients with ventricular
tachycardia had a history of 2.8 ± 2.0 episodes of ven-
tricular tachycardia.
Follow-up. The mean follow-up time for the 44 patients
was 18.2 months (range 12 to 32).
Electrophysiologic study(Table 1). Of the 44 patients,
26 (59%) had a positive electrophysiologic study, defined
as the reproducible induction of ventricular tachycardia of
three or more beats occurring by intraventricular reentry.
Thirty-four of the 44 had a control electrophysiologic study
while not taking any antiarrhythmic medications, with 32
of the studies being positive. Of the 26 patients with in-
ducible ventricular tachycardia, 14 had inducible sustained
ventricular tachycardia and 12 had nonsustained ventricular
tachycardia of 3 to 13 beats (mean 5.9 ± 3.2). Of the
patients with a positive electrophysiologic study, 88% had
Table 1. Clinical Outcome as Predicted by Electrophysiologic
(EP) Study
Follow-Up
No. of Sudden Recurrent Sudden Death
Patients Death VT or VT
Positive EP study 26 II 12 23 (88%)
(p < 0.(01)
Negative EP study 18 0 1(6%)
VT = ventricular tachycardia.
a poor clinical outcome compared with only 6% of the
patients with a negative study (p < 0.001), Eleven (92%)
of the 12 patients who died suddenly during the follow-up
period had a positive electrophysiologic test. Seventeen (85%)
of the 20 patients with a good clinical outcome had a neg-
ative electrophysiologic study.
The only complication occurring as an apparent result
of electrophysiologic study was deep venous thrombosis of
the leg noted 48 hours after study in a patient with congestive
heart failure and bilateral leg edema. The patient was treated
with a short course of heparin and 3 months of warfarin.
Ambulatory electrocardiographic monitoring. Con-
trol Holter monitoring was carried out shortly after admis-
sion, with all patients demonstrating ventricular tachycardia,
either sustained (requiring chest thump, pacing or electrical
cardioversion for termination) or nonsustained (three or more
consecutive beats at a rate greater than 100 beats/min, ter-
minating spontaneously). Nine of the patients were taking
antiarrhythmic drugs during the period of Holter monitoring
because sustained, hemodynamically unstable ventricular
tachycardia on admission precluded drug discontinuation.
The remaining 35 patients had 24 to 72 hour Holter mon-
itoring (mean duration 40 ± 19) while not taking any an-
tiarrhythmic drugs (excluding digoxin and beta-adrenergic
blocking agents for angina control). The average number
of episodes of nonsustained ventricular tachycardia in these
patients was 4.5 ± 6.0/24 h, and the average duration of
ventricular tachycardia was 17 ± 24.5 beats. Holter mon-
itoring was again carried out for 48 to 72 hours immediately
before the electrophysiologic study, with the antiarrhythmic
regimen being the same as that during the electrophysiologic
study. Three patients had 24 hours of ambulatory i.ectro-
cardiographic monitoring, 13 patients had 48 hours and 28
patients had 72 hours. The mean duration of Holter moni-
toring for the 44 patients was 61.6 ± 12 hours.
The discharge ambulatory electrocardiographic moni-
toring results were grouped as a function of an arrhythmia
classification scheme (Table 2) (15). In the 10 patients with
persistent nonsustained ventricular tachycardia on the dis-
charge Holter record, the average number of episodes of
ventricular tachycardia was 3.1 ± 1.0, and the average
duration of each episode was 3.9 ± 2.5 beats. There was
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Arrhythmia
Class*
o
I
2
3
4a
4b
No. of
Patients
3
7
4
8
12
10
Sudden
Death
I
3
I
2
4
I
Recurrent
VT
o
3
I
2
o
6
Sudden Death
or VT
1(33%)
6 (86%)
2 (50%)
4 (50%)
4 (33%)
7 (70%)
*Class 0 no premature ventricular complexes present; class I = occasional premature ventricular
complexes « 30th); class 2 = frequent premature ventricular complexes (~ 30th); class 3 = presence of
multiform premature ventricular complexes; class 4a = presence of two consecutive ventricular extrasystoles;
class 4b = presence of three or more consecutive ventricular extrasystoles. VT = ventricular tachycardia.
Table 4. Antiarrhythmic Drugs Used in 44 Patients With Life-
Threatening Ventricular Arrhythmias
after maintained are shown in Table 4. Beta-adrenergic
blocking agents were used for the management of angina
pectoris (12 patients) or hypertrophic obstructive cardio-
myopathy (1 patient). Nine patients taking digitalis because
of a history of congestive heart failure were maintained on
this drug. Of the two patients maintained without medica-
tions, one had recurrent ventricular tachycardia and ven-
tricular fibrillation associated with heavy alcohol intake, and
no clinical recurrence of the arrhythmias after discontinuing
all alcohol consumption.
The three patients with afalse positive electrophysiologic
study, that is, having a good clinical outcome despite a
positive test, were taking one or more of the following
antiarrhythmic drugs: quinidine, procainamide, a beta-ad-
renergic blocking agent and digoxin. Two of these patients
had inducible sustained ventricular tachycardia that required
external cardioversion, and the third had inducible nonsus-
tained ventricular tachycardia of seven beats' duration. One
of these three patients with a false positive test had recently
Poor Clinical Response
little correlation between arrhythmia class and ultimate clin-
ical outcome.
Table 3 compares the presence and absence of ventric-
ular tachycardia of three or more beats at a rate greater than
100 beats/min on ambulatory electrocardiographic moni-
toring. Seven (70%) of 10 patients with a positive recording
had either sudden death or recurrent ventricular tachycardia
on follow-up study, compared with 17 (50%) of 34 patients
with a negative recording by this criterion. This does not
represent a significant difference (p = 0.26). Eleven (92%)
of the 12 patients who died suddenly during the follow-up
period had a negative Holter recording, that is, the absence
of three or more beats of ventricular tachycardia. Seventeen
(85%) of the 20 patients with a good clinical outcome had
a negative Holter recording, although premature ventricular
complexes might have been present.
Antiarrhythmic drugs. The number of antiarrhythmic
drugs that each patient had attempted to take and discon-
tinued because of continued ventricular tachycardia during
programmed electrical stimulation or because of patient in-
tolerance or toxicity was 4.4 ± 2.1. The drugs were dis-
continued because of inefficacy in 82% and intolerance or
toxicity in 18%. The antiarrhythmic drug regimens on which
the 44 patients underwent electrophysiologic study and am-
bulatory electrocardiographic monitoring and were there-
Table 3. Clinical Outcome as Predicted by Ventricular
Tachycardia* on Ambulatory Electrocardiographic Monitoring
Follow-Up
No. of Sudden Recurrent Sudden Death
Patients Death VT or VT
VT
Present 10 1 6 7 (70%)
Absent 34 II 6 17 (50%)
p Value = 0.26
*Ventricular tachycardia (VT) is defined here as the presence of three
or more beats of ventricular tachycardia on discharge Holter monitoring.
Good Clinical
Response
(n = 20)
Quinidine 2
Procainamide 9
Disopyrarnide 3
Phenytoin 0
Aprindine I
Tocainide I
Flecainide 0
Amiodarone 0
Verapamil 0
Beta-adrenergic 6
blocker
Digoxin 6
None I
VT = ventricular tachycardia.
Sudden Death
(n = 12)
5
o
o
o
4
I
I
I
o
2
2
o
Recurrent VT
(n = 12)
4
I
I
I
5
I
o
I
I
7
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Figure 1. Kaplan-Meier life table plots of patients undergoing
electrophysiologic (E-P) study (A) and ambulatory electrocardio-
graphic (Holter) monitoring (B). Good clinical response is defined
as the absence of sudden death or recurrent ventricular tachycardia
in follow-up study. A, The response of patients with a positive
electrophysiologic study is significantly poorer than that of patients
with a negative study. B, There is no significant difference in
clinical response between patients with a positive ambulatory
electrocardiographic recording compared with those with a neg-
ative recording.
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Table 5. Summary of the Comparative Predictive Clinical
Value of Electrophysiologic (EP) Study and Ambulatory
Electrocardiographic (Holter) Monitoring
sustained an acute myocardial infarction 4Y2 weeks before
his electrophysiologic study, No other patient had sustained
a myocardial infarction in such close temporal proximity to
electro physiologic study.
Comparison of electrophysiologic study and ambu-
latory electrocardiographic monitoring. The positive and
negative predictive values and predictive accuracy of each
test are summarized in Table 5. The positive predictive value
(that is, the percent of patients with a positive test who had
an unfavorable outcome) shows no significant difference
between the electrophysiologic study and Holter monitoring.
The negative predictive value (that is, the percent of patients
with a negative test who had a good clinical outcome) is
significantly higher (94 versus 50%) for the electrophysi-
ologic study (p < 0.002). Thus, the predictive accuracy,
which reflects both the true positive and true negative results
in a test population, is significantly higher for the electro-
physiologic study than for ambulatory electrocardiographic
monitoring, primarily because of frequent false negative
tests in the latter.
Life table analysis. Figure 1 shows the Kaplan-Meier
life table plots of patients undergoing electrophysiologic
study and ambulatory electrocardiographic monitoring, re-
spectively. A good clinical response, defined as the absence
of sudden death or symptomatic sustained ventricular tachy-
cardia during follow-up, is plotted as a function of the du-
ration of follow-up after electrophysiologic study and am-
bulatory electrocardiographic monitoring. Figure lA shows
the significantly poorer response in patients with a positive
test compared with those with a negative test (p < 0.001).
Figure IB shows the life table analysis plotted as a function
of positive or negative ambulatory electrocardiographic re-
cording, that is, the presence or absence of three or more
beats of ventricular tachycardia on the predischarge Holter
recording obtained near the time of electrophysiologic study.
Although there appeared to be a trend, the difference in
clinical response between the two techniques was not sta-
tistica lIy significant (p = 0.11).
EP Study Holter p Value
Positix e predictive value 88% 70% = 0.32
TP/TP + FP)
Negative predictive value 94% 50% < 0.002
TN!(TN + FN)
Predic uve accuracy 91% 55% < 0.001
(TP + TN)/Entire pop
Entire pop = entire test population; FN = false negative tests; FP =
false positive tests; TN = true negative tests; TP = true positive tests.
Discussion
Programmed electrical stimulation. Our study shows
that programmed electrical stimulation has a high predictive
accuracy in determining long-term antiarrhythmic drug ef-
ficacy for at least 18 months in patients with a history of
primary ventricular fibrillation or recurrent ventricular
tachycardia. In addition, the electrophysiologic study has a
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higher predictive value than the 24 hour ambulatory electro-
cardiographic recording when the latter is analyzed with
respect to a common arrhythmia classification scheme (IS).
This is consistent with the findings of Herling et al. (8),
who performed 24 hour Holter monitoring in 23 patients
with recurrent ventricular tachycardia, and concluded that
the response of ventricular ectopic activity on Holter mon-
itoring to antiarrhythmic or surgical therapy did not predict
therapeutic success. In a recent study by Chua et al. (16),
comparing programmed stimulation with ambulatory mon-
itoring in patients similar to ours, programmed stimulation
was highly predictive of long-term outcome, whereas am-
bulatory monitoring was found to be of limited value. The
high predictive accuracy of electrophysiologic testing has
been repeatedly demonstrated by numerous investigators in
patients with recurrent ventricular tachycardia (3,4,17-21)
and ventricular fibrillation (2,22).
Controversy and lack of uniformityremain prevalent among
clinical electrophysiologists with regard both to the pacing
techniques used to initiate tachyarrhythmias in the cathe-
terization laboratory and to the number of elicited ventricular
responses used to define a positive electrophysiologic test
(that is, the number of induced ventricular tachycardia beats
above which a given antiarrhythmic drug regimen would be
considered a failure). Pacing protocols now in use include
right or left (or both) ventricular single and double premature
extrastimuli during ventricular pacing and brief bursts of
rapid ventricular pacing (2 to 10 beats), which have been
used commonly by many investigators (1-4,18-20,23,24),
as well as triple premature ventricular stimuli and pacing
during isoproterenol infusion, which have been used by a
few groups (1,3,4). We used a pacing protocol of single
and double extrastimuli during ventricular pacing and a burst
of 10 ventricular paced beats from the right or left ventricle
(or both), which is commonly used and whose sensitivity
in this high risk patient group has been examined (23,25,26).
Although the ablation of any inducible ventricular tachy-
cardia is sought in each patient after an antiarrhythmic drug
is tested, Josephson and Horowitz (27) emphasized that only
the induction of sustained ventricular tachycardia need be
ablated for a drug to be considered successful. In contrast,
Mason and Winkle (3) considered a drug prophylactic if
five or fewer beats of ventricular tachycardia could be in-
duced, and Ruskin et al. (2) defined arrhythmia suppression
as the induction of no more than two repetitive ventricular
responses after antiarrhythmic drug administration. In the
present study, the induction of three or more beats of ven-
tricular tachycardia was used to define a positive electro-
physiologic test, because we have previously shown (26)
that the predictive accuracy is maximized using our stim-
ulation techniques when this criterion is used in patients
with life-threatening ventricular arrhythmias.
Ambulatory electrocardiographic (Holter) monitoring.
In these high risk patients, a commonly used classification
system (IS) of ambulatory electrocardiographic monitoring
did not adequately stratify patients according to risk of re-
currence of sudden death or ventricular tachycardia. We did
not use the Lown grade 5 category (IS), that is, the presence
of the R on T wave premature ventricular complexes, be-
cause several investigators (28-32) showed that patients in
this group may not be at particularly high risk of sustained
ventricular tachyarrhythmias. The criterion of three or more
beats of ventricular tachycardia on ambulatory electrocar-
diographic monitoring was used in this study to define a
positive test to maximize the predictive value of the test.
Follansbee et al. (31) and Bigger and Weld (32), the latter
in a study of postmyocardial infarction patients, showed that
the presence of ventricular tachycardia of three or more beats
identifies a group of patients at highest risk of subsequent
sudden death; higher than that identified by premature ven-
tricular complex frequency, multiformity, presence of paired
premature ventricular complexes or presence of R on T
phenomenon.
Despite using the criterion of three or more beats of
ventricular tachycardia to define a positive Holter recording,
in our study the ambulatory electrocardiographic recording
correctly predicted 70% of those patients who later died
suddenly or had recurrent ventricular tachycardia and only
50% of those patients who had a good clinical outcome. Of
those 12 patients who died during follow-up, only I had a
positive Holter recording. This emphasizes that the primary
limitation of the ambulatory electrocardiographic recording
in this select, high risk patient group is likely due to the
high false negative rate. Holter monitoring remains, nonthe-
less, a keystone in the rapid noninvasive identification of
high risk subgroups (31,33-36). The presence of three or
more beats of ventricular tachycardia indicates a relatively
high likelihood of future sudden death or recurrent symp-
tomatic ventricular tachycardia in both our study and those
of others (31,33). This study points out the limitations of a
negative ambulatory electrocardiographic monitoring and
the advantage of specialized supplementary tests such as the
electrophysiologic study in these high risk patients.
Limitations of the study. The predictive accuracy of a
test may vary, depending on the specific patients studied,
the method of testing and the specific methods used to delin-
eate positive and negative test results. It is important to
emphasize that by nature of the study design, this is a highly
selected group because of the extremely high risk in these
patients with recurrent ventricular tachycardia or fibrillation,
and by virtue of their remaining on the fixed drug regimen
during the follow-up period. We felt that it was important
that patients whose antiarrhythmic drug regimen was changed
after discharge, for reasons such as intolerable side effects
or noncompliance, be excluded from study, because of the
assumption that any change in antiarrhythmic blood levels
might alter the cardiac "substrate," and that the potential
for cardiac arrhythmias would change. Thus, this indepen-
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dent variable, antiarrhythmic drug dosage, was kept fixed
by excluding patients whose drug regimen was altered dur-
ing the follow-up period.
A longer period of ambulatory electrocardiographic mon-
itoring beyond the average of 61. 6 ± 12 hours of continuous
monitoring in this study might have shown different results.
Indeed, several studies (37-39) have shown that because of
variability of arrhythmia frequency, detection of ventricular
arrhythmias is a function of the monitoring time. In general,
our practice has been to obtain 3 continuous days of re-
cordings after making a change in each patient's antiar-
rhythmic regimen. Only 3 of our 44 patients had no ven-
tricular ectopic beats on their discharge Holter recording.
Thus, it is possible that complete suppression of ectopic
activity in this group would have resulted in a good clinical
outcome (Table 2). In addition, the use of other criteria for
a positive and negative test result might have improved the
predictive accuracy of the Holter recording.
Although the electrophysiologic study appeared to ac-
curately predict long-term efficacy of antiarrhythmic drugs
as a group, it should not be assumed that this will be true
for all drugs. Reports (40-42) have indicated, for example,
that electrophysiologic studies carried out in patients taking
amiodarone may not predict long-term clinical outcome.
Although the mechanism is unclear, it appears that such
patients may do well clinically, despite a positive electro-
physiologic study. Only two of our patients were taking
amiodarone; both had positive electrophysiologic studies
and both had a poor clinical outcome (one died suddenly
and the other had recurrent ventricular tachycardia). A re-
lated issue is that of the possible "proarrhythmic" effect
of antiarrhythmic agents and the need for a control electro-
physiologic study with the patient not receiving any agents
whenever possible. Such a control study was not carried out
in 10 of our 44 patients because of persistent, hemodynam-
ically unstable ventricular tachycardia on admission. It should
be recognized that the ability to induce ventricular tachy-
cardia III the electrophysiology laboratory may result from
the antiarrhythmic agent itself, as recently emphasized by
Ruskin et al. (43). Thus, it is possible that some of these
10 patients may have had a positive electrophysiologic study
or Holter monitor recording, or both, because of the drug
administered, and that the antiarrhythmic therapy might be
causally related to the occurrence of sudden death.
Conclusion. On the basis of this study, we conclude
that in the management of patients with primary ventricular
fibrillation or recurrent ventricular tachycardia, the clinician
should be cognizant of the limitations of ambulatory electro-
cardiographic monitoring. A positive Holter recording,
showing three or more beats of ventricular tachycardia, may
be predictive of a poor clinical outcome in this group; yet
the absence of three or more beats of ventricular tachycardia
on a 48 to 72 hour record is not an accurate predictor of a
good clinical outcome. The electrophysiologic study, how-
ever, has advantages over ambulatory electrocardiographic
monitoring in this high risk group of patients by providing
a high degree of accuracy in predicting long-term clinical
response, both failures and successes, to antiarrhythmic drugs
for at least 18 months.
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